Abansado, Ronielen C.

HRN: 15-39-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2022
CEFTRIAXONE 1G (VIAL)
10/09/2022
10/15/2022
IV
700mg
Q12
Benign Febrile Convulsion T/c UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: